{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:53:13Z","timestamp":1756810393512},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00403-019-01934-9","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T18:46:51Z","timestamp":1559414811000},"page":"589-594","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Macrophage migration inhibitory factor polymorphism (rs755622) in alopecia areata: a possible role in disease prevention"],"prefix":"10.1007","volume":"311","author":[{"given":"Fateme","family":"Rajabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa M.","family":"Amoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza M.","family":"Robati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Almasi-nasrabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navid","family":"Jabalameli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,1]]},"reference":[{"key":"1934_CR1","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.160.12.5693","volume":"160","author":"RS Apte","year":"1998","unstructured":"Apte RS, Sinha D, Mayhew E, Wistow G, Niederkorn J (1998) Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol 160:5693\u20135696","journal-title":"J Immunol"},{"key":"1934_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1530\/rep.1.00857","volume":"131","author":"F Arcuri","year":"2006","unstructured":"Arcuri F, Cintorino M, Carducci A, Papa S, Riparbelli M, Mangioni S, Di Blasio A, Tosi P, Vigano P (2006) Human decidual natural killer cells as a source and target of macrophage migration inhibitory factor. Reproduction 131:175\u2013182","journal-title":"Reproduction"},{"key":"1934_CR3","first-page":"389","volume":"52","author":"CM Denkinger","year":"2004","unstructured":"Denkinger CM, Metz C, Fingerle-Rowson G, Denkinger MD, Forsthuber T (2004) Macrophage migration inhibitory factor and its role in autoimmune diseases. Arch Immunol Ther Exp (Warsz) 52:389\u2013400","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"1934_CR4","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1002\/art.10492","volume":"46","author":"R Donn","year":"2002","unstructured":"Donn R, Alourfi Z, De Benedetti F, Meazza C, Zeggini E, Lunt M, Stevens A, Shelley E, Lamb R, Ollier WE (2002) Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheumatol 46:2402\u20132409","journal-title":"Arthritis Rheumatol"},{"key":"1934_CR5","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1002\/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#","volume":"44","author":"Donn R, Shelley E, Ollier W, Thomson W, Group BPRS","year":"2001","unstructured":"Donn R, Shelley E, Ollier W, Thomson W, Group BPRS (2001) A novel 5\u2032-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 44:1782\u20131785","journal-title":"Arthritis Rheum"},{"key":"1934_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.0022-202X.2004.23314.x","volume":"123","author":"RP Donn","year":"2004","unstructured":"Donn RP, Plant D, Jury F, Richards HL, Worthington J, Ray DW, Griffiths CE (2004) Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J Invest Dermatol 123:484\u2013487","journal-title":"J Invest Dermatol"},{"key":"1934_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S1357-4310(97)01133-7","volume":"3","author":"SC Donnelly","year":"1997","unstructured":"Donnelly SC, Bucala R (1997) Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease. Mol Med Today 3:502\u2013507","journal-title":"Mol Med Today"},{"key":"1934_CR8","first-page":"268","volume":"31","author":"A Foote","year":"2004","unstructured":"Foote A, Briganti EM, Kipen Y, Santos L, Leech M, Morand EF (2004) Macrophage migration inhibitory factor in systemic lupus erythematosus. J Rheumatol 31:268\u2013273","journal-title":"J Rheumatol"},{"key":"1934_CR9","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1038\/jid.2010.260","volume":"130","author":"A Gilhar","year":"2010","unstructured":"Gilhar A (2010) Collapse of immune privilege in alopecia areata: coincidental or substantial? J Invest Dermatol 130:2535\u20132537","journal-title":"J Invest Dermatol"},{"key":"1934_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1517\/14728220903551304","volume":"14","author":"D Greven","year":"2010","unstructured":"Greven D, Leng L, Bucala R (2010) Autoimmune diseases: MIF as a therapeutic target. Expert Opin Ther Tar 14:253\u2013264","journal-title":"Expert Opin Ther Tar"},{"key":"1934_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fgene.2018.00055","volume":"9","author":"O Illescas","year":"2018","unstructured":"Illescas O, Gomez-Verjan JC, Garc\u00eda-Vel\u00e1zquez L, Govezensky T, Rodriguez-Sosa M (2018) Macrophage migration inhibitory factor \u2013\u00a0173\u00a0G\/C polymorphism: a global meta-analysis across the disease spectrum. Front Genet 9:55","journal-title":"Front Genet"},{"key":"1934_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0002-9440(10)63151-3","volume":"164","author":"T Ito","year":"2004","unstructured":"Ito T, Ito N, Bettermann A, Tokura Y, Takigawa M, Paus R (2004) Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 164:623\u2013634","journal-title":"Am J Pathol"},{"key":"1934_CR13","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/j.0022-202X.2005.23927.x","volume":"125","author":"T Ito","year":"2005","unstructured":"Ito T, Ito N, Saathoff M, Stampachiacchiere B, Bettermann A, Bulfone-Paus S, Takigawa M, Nickoloff BJ, Paus R (2005) Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol 125:1139\u20131148","journal-title":"J Invest Dermatol"},{"key":"1934_CR14","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/sj.jid.5701183","volume":"128","author":"T Ito","year":"2008","unstructured":"Ito T, Ito N, Saatoff M, Hashizume H, Fukamizu H, Nickoloff BJ, Takigawa M, Paus R (2008) Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol 128:1196\u20131206","journal-title":"J Invest Dermatol"},{"key":"1934_CR15","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1038\/jid.2010.180","volume":"130","author":"H Kang","year":"2010","unstructured":"Kang H, Wu W-Y, Lo BK, Yu M, Leung G, Shapiro J, McElwee KJ (2010) Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss. J Invest Dermatol 130:2677\u20132680","journal-title":"J Invest Dermatol"},{"key":"1934_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/1529-0131(200004)43:4<827::AID-ANR13>3.0.CO;2-K","volume":"43","author":"M Leech","year":"2000","unstructured":"Leech M, Metz C, Bucala R, MorAnd EF (2000) Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis. Arthritis Rheumatol 43:827\u2013833","journal-title":"Arthritis Rheumatol"},{"key":"1934_CR17","doi-asserted-by":"publisher","first-page":"461208","DOI":"10.1155\/2015\/461208","volume":"2015","author":"I Matia-Garc\u00eda","year":"2015","unstructured":"Matia-Garc\u00eda I, Salgado-Goytia L, Mu\u00f1oz-Valle JF, Garc\u00eda-Arellano S, Hern\u00e1ndez-Bello J, Salgado-Bernab\u00e9 AB, Parra-Rojas I (2015) Macrophage migration inhibitory factor promoter polymorphisms (-794 CATT 5\u20138 and-173 G> C): relationship with mRNA expression and soluble MIF levels in young obese subjects. Dis Markers 2015:461208","journal-title":"Dis Markers"},{"key":"1934_CR18","first-page":"1077","volume":"159","author":"K Meyer","year":"2008","unstructured":"Meyer K, Klatte J, Dinh H, Harries M, Reithmayer K, Meyer W, Sinclair R, Paus R (2008) Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol 159:1077\u20131085","journal-title":"Br J Dermatol"},{"key":"1934_CR19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/jid.2013.464","volume":"134","author":"SA Mirzoyev","year":"2014","unstructured":"Mirzoyev SA, Schrum AG, Davis MD, Torgerson RR (2014) Lifetime incidence risk of alopecia areata estimated at 2.1 percent by rochester epidemiology project, 1990\u20132009. J Invest Dermatol 134:1141","journal-title":"J Invest Dermatol"},{"key":"1934_CR20","first-page":"2605","volume":"7","author":"R Morales-Zambrano","year":"2014","unstructured":"Morales-Zambrano R, Bautista-Herrera LA, De la Cruz-Mosso U, Villanueva-Quintero GD, Padilla-Guti\u00e9rrez JR, Valle Y, Parra-Rojas I, Rangel-Villalobos H, Guti\u00e9rrez-Ure\u00f1a SR, Mu\u00f1oz-Valle JF (2014) Macrophage migration inhibitory factor (MIF) promoter polymorphisms (\u2212\u00a0794 CATT5\u20138 and \u2013\u00a0173\u00a0G\u2009>\u2009C): association with MIF and TNF\u03b1 in psoriatic arthritis. Int J Clin Exp Med 7:2605","journal-title":"Int J Clin Exp Med"},{"key":"1934_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1365-2362.2001.00796.x","volume":"31","author":"H Murakami","year":"2001","unstructured":"Murakami H, Akbar SMF, Matsui H, Onji M (2001) Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest 31:337\u2013343","journal-title":"Eur J Clin Invest"},{"key":"1934_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1365-4632.2009.04238.x","volume":"49","author":"MR Namazi","year":"2010","unstructured":"Namazi MR, Fallahzadeh MK, Shaghelani H, Kamali-Sarvestani E (2010) Marked elevation of serum macrophage migration inhibitory factor levels in patients with pemphigus vulgaris. Int J Dermatol 49:146\u2013148","journal-title":"Int J Dermatol"},{"key":"1934_CR23","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1177\/000348940111001108","volume":"110","author":"R Ohwatari","year":"2001","unstructured":"Ohwatari R, Inuyama Y, Fukuda S, Ono\u00e9 K, Iwabuchi K, Nishihira J (2001) Serum level of macrophage migration inhibitory factor as a useful parameter of clinical course in patients with Wegener\u2019s granulomatosis and relapsing polychondritis. Ann Oto Rhinol Laryn 110:1035\u20131040","journal-title":"Ann Oto Rhinol Laryn"},{"key":"1934_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","volume":"51","author":"EA Olsen","year":"2004","unstructured":"Olsen EA, Hordinsky MK, Price VH, Roberts JL, Shapiro J, Canfield D, Duvic M, King LE, McMichael AJ, Randall VA (2004) Alopecia areata investigational assessment guidelines-part II. J Am Acad Dermatol 51:440\u2013447","journal-title":"J Am Acad Dermatol"},{"key":"1934_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature09114","volume":"466","author":"L Petukhova","year":"2010","unstructured":"Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, Kim H, Singh P, Lee A, Chen WV (2010) Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 466:113","journal-title":"Nature"},{"key":"1934_CR26","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/bjd.16808","volume":"179","author":"F Rajabi","year":"2018","unstructured":"Rajabi F, Drake L, Senna M, Rezaei N (2018) Alopecia areata: a review of disease pathogenesis. Br J Dermatol 179:1033\u20131048","journal-title":"Br J Dermatol"},{"key":"1934_CR27","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2019.1597109","author":"F Rajabi","year":"2019","unstructured":"Rajabi F, Amoli MM, Robati RM, Almasi-Nasrabadi M, Jabalameli N, Moravvej H (2019) The Association between Genetic Variation in Wnt Transcription Factor TCF7L2 (TCF4) and Alopecia Areata. Immunol Invest. https:\/\/doi.org\/10.1080\/08820139.2019.1597109","journal-title":"Immunol Invest"},{"key":"1934_CR28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.4049\/jimmunol.165.2.710","volume":"165","author":"AC Repp","year":"2000","unstructured":"Repp AC, Mayhew ES, Apte S, Niederkorn JY (2000) Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells. J Immunol 165:710\u2013715","journal-title":"J Immunol"},{"key":"1934_CR29","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/j.1468-3083.2012.04676.x","volume":"27","author":"M Saeedi","year":"2013","unstructured":"Saeedi M, Amoli M, Robati R, Sayahpour F, Namazi N, Toossi P (2013) Macrophage migration inhibitory factor gene polymorphism is not associated with pemphigus vulgaris in Iranian patients. J Eur Acad Dermatol Venereol 27:1127\u20131131","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1934_CR30","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/ijd.13344","volume":"55","author":"SA Salem","year":"2016","unstructured":"Salem SA, Asaad MK, Elsayed SB, Sehsah HM (2016) Evaluation of macrophage migration inhibitory factor (MIF) levels in serum and lesional skin of patients with alopecia areata. Int J Dermatol 55:1357\u20131361","journal-title":"Int J Dermatol"},{"key":"1934_CR31","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0091-6749(99)70339-8","volume":"104","author":"T Shimizu","year":"1999","unstructured":"Shimizu T, Abe R, Ohkawara A, Nishihira J (1999) Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis. J Allergy Clin Immun 104:659\u2013664","journal-title":"J Allergy Clin Immun"},{"key":"1934_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/sj.gene.6364191","volume":"6","author":"T Shimizu","year":"2005","unstructured":"Shimizu T, Hizawa N, Honda A, Zhao Y, Abe R, Watanabe H, Nishihira J, Nishimura M, Shimizu H (2005) Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata. Genes Immun 6:285\u2013289","journal-title":"Genes Immun"},{"key":"1934_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1046\/j.0022-202x.2001.01669.x","volume":"118","author":"T Shimizu","year":"2002","unstructured":"Shimizu T, Mizue Y, Abe R, Watanabe H, Shimizu H (2002) Increased macrophage migration inhibitory factor (MIF) in the sera of patients with extensive alopecia areata. J Invest Dermatol 118:555","journal-title":"J Invest Dermatol"},{"key":"1934_CR34","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1046\/j.0022-202x.2001.01366.x","volume":"116","author":"T Shimizu","year":"2001","unstructured":"Shimizu T, Nishihira J, Mizue Y, Nakamura H, Abe R, Watanabe H, Ohkawara A, Shimizu H (2001) High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis. J Invest Dermatol 116:989\u2013990","journal-title":"J Invest Dermatol"},{"key":"1934_CR35","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1046\/j.0022-202x.2001.01366.x","volume":"116","author":"T Shimizu","year":"2001","unstructured":"Shimizu T, Nishihira J, Mizue Y, Nakamura H, Abe R, Watanabe H, Ohkawara A, Shimizu H (2001) High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis. J Invest Dermatol 116:989\u2013990","journal-title":"J Invest Dermatol"},{"key":"1934_CR36","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/jcp.21346","volume":"215","author":"S Stosic-Grujicic","year":"2008","unstructured":"Stosic-Grujicic S, Stojanovic I, Maksimovic-Ivanic D, Momcilovic M, Popadic D, Harhaji L, Miljkovic D, Metz C, Mangano K, Papaccio G (2008) Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus. J Cell Physiol 215:665\u2013675","journal-title":"J Cell Physiol"},{"key":"1934_CR37","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nri1224","volume":"3","author":"JW Streilein","year":"2003","unstructured":"Streilein JW (2003) Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 3:879","journal-title":"Nat Rev Immunol"},{"key":"1934_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/jcla.21731","volume":"29","author":"DNA Younan","year":"2015","unstructured":"Younan DNA, Agamia N, Elshafei A, Ebeid N (2015) Serum level of macrophage migration inhibitory factor (MIF) in Egyptians with alopecia areata and its relation to the clinical severity of the disease. J Clin Lab Anal 29:74\u201379","journal-title":"J Clin Lab Anal"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-019-01934-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-019-01934-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-019-01934-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T03:50:18Z","timestamp":1694922618000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-019-01934-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["1934"],"URL":"https:\/\/doi.org\/10.1007\/s00403-019-01934-9","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,1]]},"assertion":[{"value":"11 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics commitee of Shahid Beheshti University of Medical Sciences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval (research involving human participants and\/or animals)"}},{"value":"A written informed consent was obtained from all participants according to the declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}